All Pathways
NeurologyManagement

Multiple Sclerosis Acute Relapse Management

Multiple Sclerosis Acute Relapse Management: Suspected MS Relapse → Confirm True Relapse → Pseudorelapse? → Treat Underlying Trigger.

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected MS Relapse

    New or worsening neurological symptoms in MS patient

    1. Action

      Confirm True Relapse

      Rule out pseudorelapse

      • New symptoms lasting >24 hours
      • No fever or infection present
      • At least 30 days since last relapse
      • Exclude UTI, other infections
      • Check for medication changes
      1. Decision

        Pseudorelapse?

        Transient worsening due to other factors

        • Infection (UTI most common)
        • Fever, heat exposure
        • Stress, fatigue
        • Uhthoff's phenomenon
        1. Action

          Treat Underlying Trigger

          Address pseudorelapse cause

          • Treat infection (antibiotics if UTI)
          • Reduce body temperature
          • Rest, hydration
          • Symptoms resolve when trigger addressed
        2. Decision

          Assess Relapse Severity

          Mild vs moderate/severe

          • Sensory-only: often mild
          • Motor weakness: moderate/severe
          • Optic neuritis: moderate
          • Brainstem symptoms: can be severe
          • Functional impairment level
          1. Action

            Mild Relapse

            Observation may be reasonable

            • Purely sensory symptoms
            • Minimal functional impact
            • Steroids optional
            • Steroids shorten duration, not final outcome
            • Patient preference matters
            1. Action

              High-Dose Corticosteroids

              First-line for moderate/severe relapse

              • IV methylprednisolone 1g daily × 3-5 days
              • OR high-dose oral prednisone 1250 mg daily × 3-5 days
              • No taper typically needed for short course
              • Shortens relapse duration
              • Does NOT affect long-term outcome
              1. Warning

                ⚠️ Steroid Precautions

                Monitor for adverse effects

                • Check glucose (especially in diabetics)
                • GI prophylaxis (PPI if needed)
                • Insomnia, mood changes common
                • Avoid in active infection
                • Caution in osteoporosis
              2. Decision

                Response to Steroids?

                Evaluate after 5-7 days

                • Most improve within 3-5 days
                • Full recovery may take weeks
                • Incomplete recovery common
                1. Action

                  Good Response

                  Continue observation

                  • Monitor for full recovery
                  • May take weeks to months
                  • Physical therapy if motor deficit
                  • Review DMT efficacy
                  1. Action

                    Review DMT Strategy

                    Relapse indicates possible DMT failure

                    • First relapse on DMT: may continue same
                    • Multiple relapses: consider switching
                    • Escalate to higher-efficacy DMT
                    • Discuss with MS specialist
                    1. Outcome

                      Follow-up Plan

                      Post-relapse care

                      • Neurology follow-up in 4-6 weeks
                      • Consider repeat MRI in 3 months
                      • DMT adherence counseling
                      • Patient education on relapse signs
                  2. Action

                    Rehabilitation

                    Maximize recovery

                    • Physical therapy for motor deficits
                    • Occupational therapy for function
                    • Vision therapy for optic neuritis
                    • Cognitive rehabilitation if needed
                2. Action

                  Poor or No Response

                  Consider escalation

                  • Additional steroid course (controversial)
                  • Plasma exchange (PLEX)
                  • ACTH gel (Acthar) alternative
                  • Specialist consultation
                  1. Action

                    Plasma Exchange (PLEX)

                    For steroid-refractory severe relapse

                    • 5-7 exchanges over 10-14 days
                    • Best evidence for severe relapses
                    • Optic neuritis, myelitis, brainstem
                    • Requires central access
                    • ~40-50% response rate if steroids fail

Guideline Source

Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis - AAN

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not address DMT selection in detail
  • PLEX availability varies by center
  • Pseudorelapse must be ruled out
  • Pediatric MS may differ

Applicable Regions

USEUglobal

EU: ECTRIMS recommendations similar

US: AAN guidelines followed

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Multiple Sclerosis Acute Relapse Management?

The Multiple Sclerosis Acute Relapse Management is a management clinical algorithm for Neurology. It provides a structured decision tree to guide clinical decision-making, based on Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis - AAN.

What guideline is the Multiple Sclerosis Acute Relapse Management based on?

This algorithm is based on Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis - AAN (DOI: 10.1212/WNL.0000000000005347).

What are the limitations of the Multiple Sclerosis Acute Relapse Management?

Known limitations include: Does not address DMT selection in detail; PLEX availability varies by center; Pseudorelapse must be ruled out; Pediatric MS may differ. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Multiple Sclerosis Acute Relapse Management appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free